Sitagliptin and Acute Pancreatitis: A Systematic Review and Meta-analysis
Hyder Osman Mirghani, Salem Ahmed S. Shaman S. Shaman & Ibrahim Mahmoud Hussain Aljwah · Journal of Pharmaceutical Research International · 2021
Background and Objectives: Sitagliptin is a dipepidyl peptidase inhibitor (DPP-4i) with gentle antidiabetic effects with a lower risk of hypoglycemia. The association with acute pancreatitis is controversial. The current meta-analysis aimed to assess the relationship of sitaglipt...
Open access
Research Article
10.9734/jpri/2021/v33i50B33424